LEPU SCIENTECH MEDICAL TECHNOLOGY (SHANGHAI) (2291.HK)

Wednesday

9:52 PM

Thesis: Recent performance has been negatively impacted by regulatory challenges and competitive pressures, leading to a decline in investor sentiment.

Revenue Outlook

Metric	FY2025	FY2026E	FY2027E
Revenue	$528M	$866M	$1.1B
Rev. Growth	+11.9%	+63.9%	+26.3%
EPS	$0.69	$1.18	$1.39
EPS Growth	-2.8%	+71.6%	+17.4%
P/E (fwd)	14.8×	8.6×	7.3×

★ Analysts see FY2026 revenue reaching $866M — +63.9% growth in a single year.

What Moves the Stock

1Regulatory approvals for new medical devices
2Market penetration in international markets, particularly Southeast Asia
3Changes in healthcare spending in China
4Technological advancements in medical diagnostics
5Medical devices - 80%
6Diagnostic solutions - 15%
7Therapeutic devices - 5%
8Increased healthcare spending in China

FY2025 Snapshot

Revenue: $528M
Rev. Growth: +11.9%
Gross Margin: 84.7%
Op. Margin: 52.4%
Net Margin: 45.4%
Net Income: $240M
NI Growth: -2.4%
EPS: $0.69
1Y Return: -47.8%

2291.HK Chart

My Notes

"Management has indicated that navigating regulatory hurdles will be a key focus in the coming quarters."
Moat: LEPU's competitive advantage is bolstered by its proprietary technology and established brand reputation in China.
growth - Investors are likely attracted to LEPU for its high margins and growth potential in the medical device sector.
minimal - With zero debt, LEPU is less affected by interest rate changes, although higher rates could impact healthcare spending indirectly.
Watch on earnings: China healthcare spending growth rate, Regulatory approval timelines for new products, Market share in diagnostic devices.

One Sentence Summary:

LEPU ScienTech Medical Technology (Shanghai): the story is balanced — regulatory approvals for new medical devices.

Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.

Writing up the research note…

First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance